Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Adriamycin
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer CenterP3BB (66)
Adriamycin
Classic Hodgkin Lymphoma
Michael Spinner, MDP3BB (66)
Adriamycin
Endometrial Carcinoma
AstraZenecaP3BB (66)
Adriamycin
HER2 Positive Breast Carcinoma
Shanghai JMT-Bio Inc.P3BB (66)
Adriamycin
Inflammatory Breast Carcinoma
M.D. Anderson Cancer CenterP3BB (66)
Adriamycin
Kidney Cancer
Oliver JonasP3BB (66)
Adriamycin
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P3BB (66)
Adriamycin
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P3BB (66)
Adriamycin
Carcinoma Of Urethra
University of Southern CaliforniaP3BB (66)
Adriamycin
Sarcoma
City of Hope Medical CenterP3BB (66)
Adriamycin
Triple-Negative Breast Carcinoma
Yuan YuanP3BB (66)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Disease Related To Hematopoietic Stem Cell Transplant
The First Affiliated Hospital of Soochow UniversityP3BB (66)
Apitegromab
Neuromuscular Disease
Scholar Rock, Inc.P3BB (66)
Asparaginase
B-Cell Acute Lymphoblastic Leukemia
University of WashingtonP3BB (66)
Aspirin
Breast Carcinoma
Mayo ClinicP3BB (66)
Aspirin
Lynch Syndrome
M.D. Anderson Cancer CenterP3BB (66)
Astx727
Myelodysplastic Syndrome
Taiho Oncology, Inc.P3BB (66)
Atorvastatin
Renal Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3BB (66)
Autologous Cd34+ Cells Isolated From Mobilised Peripheral Blood By Positive Selection, Modified By Crispr/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/Crispr-Associated Protein 9) Mediated Gene Editing Consisting Of A Guide Rna (Grna) Introduced Transiently As Ribonucleoprotein (Rnp) Complex, Targeting The Erythroid Lineage-Specific Enhancer Region Of Bcl11A (B-Cell Lymphoma/Leukemia 11A). The Site-Specific Cleavage By Cas9 Forms A Double Strand Break (Dsb), Which Is Subsequently Repaired By Nonhomologous End-Joining (Nhej), Leading To The Transcriptional Repression Of Bcl11A, A Repressor Of ?-Globin Gene Transcription
Disease Of Genetic Or Genomic Mechanism
Vertex Pharmaceuticals IncorporatedP3BB (66)
Autologous Cd34+ Cells Isolated From Mobilised Peripheral Blood By Positive Selection, Modified By Crispr/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/Crispr-Associated Protein 9) Mediated Gene Editing Consisting Of A Guide Rna (Grna) Introduced Transiently As Ribonucleoprotein (Rnp) Complex, Targeting The Erythroid Lineage-Specific Enhancer Region Of Bcl11A (B-Cell Lymphoma/Leukemia 11A). The Site-Specific Cleavage By Cas9 Forms A Double Strand Break (Dsb), Which Is Subsequently Repaired By Nonhomologous End-Joining (Nhej), Leading To The Transcriptional Repression Of Bcl11A, A Repressor Of ?-Globin Gene Transcription
Hemoglobinopathy
Vertex Pharmaceuticals IncorporatedP3BB (66)
Avutometinib
Ovarian Serous Adenocarcinoma
Verastem, Inc.P3BB (66)
Axitinib
Kidney Neoplasm
PfizerP3BB (66)
Befotertinib
Non-Small Cell Lung Carcinoma
Hebei Medical University Fourth HospitalP3BB (66)
Bendamustine
B-Cell Chronic Lymphocytic Leukemia
Mayo ClinicP3BB (66)
Benzeneethanamine, N-Ethyl-?-Methyl-4-(Trifluoromethyl)-, Hydrochloride, (±)-
Lennox-Gastaut Syndrome
University of ChicagoP3BB (66)
Showing 2101 to 2125 of 42,301 assets
PreviousPage 85 of 1693Next